111 related articles for article (PubMed ID: 3896974)
1. Long-term survivors of adult acute nonlymphocytic leukemia: fact or fiction?
Rosenthal DS; Emerson SE; Rappeport JM; Moloney WC; Handin RI
Haematol Blood Transfus; 1985; 29():44-7. PubMed ID: 3896974
[TBL] [Abstract][Full Text] [Related]
2. Maintenance chemotherapy prolongs remission duration in adult acute nonlymphocytic leukemia.
Cassileth PA; Harrington DP; Hines JD; Oken MM; Mazza JJ; McGlave P; Bennett JM; O'Connell MJ
J Clin Oncol; 1988 Apr; 6(4):583-7. PubMed ID: 3282032
[TBL] [Abstract][Full Text] [Related]
3. Prolonged unmaintained remission after intensive consolidation therapy in adult acute nonlymphocytic leukemia.
Cassileth PA; Begg CB; Silber R; Spiers A; Burkart PT; Scharfman W; Knospe WH; Bennett JM; Mazza JJ; Oken MM
Cancer Treat Rep; 1987 Feb; 71(2):137-40. PubMed ID: 3802110
[TBL] [Abstract][Full Text] [Related]
4. Intensive remission consolidation therapy in the treatment of acute nonlymphocytic leukemia.
Preisler HD; Raza A; Early A; Kirshner J; Brecher M; Freeman A; Rustum Y; Azarnia N; Priore R; Sandberg A
J Clin Oncol; 1987 May; 5(5):722-30. PubMed ID: 3572463
[TBL] [Abstract][Full Text] [Related]
5. High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: an update.
Wolff SN; Herzig RH; Phillips GL; Lazarus HM; Greer JP; Stein RS; Ray WA; Herzig GP
Semin Oncol; 1987 Jun; 14(2 Suppl 1):12-7. PubMed ID: 3589687
[TBL] [Abstract][Full Text] [Related]
6. Intensive maintenance therapy improves survival in adult acute nonlymphocytic leukemia: an eight-year follow-up.
Dutcher JP; Wiernik PH; Markus S; Weinberg V; Schiffer CA; Harwood KV
Leukemia; 1988 Jul; 2(7):413-9. PubMed ID: 3393023
[TBL] [Abstract][Full Text] [Related]
7. Early intensification of chemotherapy for childhood acute nonlymphoblastic leukemia: improved remission induction with a five-drug regimen including etoposide.
Kalwinsky D; Mirro J; Schell M; Behm F; Mason C; Dahl GV
J Clin Oncol; 1988 Jul; 6(7):1134-43. PubMed ID: 3292713
[TBL] [Abstract][Full Text] [Related]
8. A systematic overview of chemotherapy effects in acute myeloid leukaemia.
Kimby E; Nygren P; Glimelius B;
Acta Oncol; 2001; 40(2-3):231-52. PubMed ID: 11441935
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcome of high-dose cytarabine-based consolidation chemotherapy for older patients with acute myelogenous leukemia.
Schiller G; Lee M
Leuk Lymphoma; 1997 Mar; 25(1-2):111-9. PubMed ID: 9130619
[TBL] [Abstract][Full Text] [Related]
10. Response of therapy-associated acute nonlymphocytic leukemia to intensive induction chemotherapy.
Duane SF; Peterson BA; Bloomfield CD; Michels SD; Hurd DD
Med Pediatr Oncol; 1985; 13(4):207-13. PubMed ID: 4010622
[TBL] [Abstract][Full Text] [Related]
11. Consolidation therapy without maintenance for acute non-lymphoblastic leukaemia.
Roberts MM; Juttner CA; Blunden RW; Horvath N; To LB; Ho JQ; Dart GW; Kimber RJ
Med J Aust; 1988 Feb; 148(4):181-3. PubMed ID: 3340044
[TBL] [Abstract][Full Text] [Related]
12. Intensive postremission therapy in adults with acute nonlymphocytic leukemia using various dose schedules of ara-C: a progress report from the CALGB. Cancer and Leukemia Group B.
Mayer RJ; Schiffer CA; Peterson BA; Budman DR; Silver RT; Rai KR; Cornwell GG; Ellison RR; Maguire M; Berg DT
Semin Oncol; 1987 Jun; 14(2 Suppl 1):25-31. PubMed ID: 3296206
[No Abstract] [Full Text] [Related]
13. Evaluation of intensive postremission chemotherapy for adults with acute nonlymphocytic leukemia using high-dose cytosine arabinoside with L-asparaginase and amsacrine with etoposide.
Tallman MS; Appelbaum FR; Amos D; Goldberg RS; Livingston RB; Mortimer J; Weiden PL; Thomas ED
J Clin Oncol; 1987 Jun; 5(6):918-26. PubMed ID: 3585446
[TBL] [Abstract][Full Text] [Related]
14. [Improved results of treatment in 30 cases of acute nonlymphocytic leukemia in childhood].
Imashuku S; Arakawa S; Todo S; Esumi N; Tsunamoto K; Hashida T; Morioka Y; Hibi S; Nagai T; Fujiwara F
Gan To Kagaku Ryoho; 1986 Aug; 13(8):2581-7. PubMed ID: 3740859
[TBL] [Abstract][Full Text] [Related]
15. Hyperleukocytosis in adult acute nonlymphocytic leukemia: impact on remission rate and duration, and survival.
Dutcher JP; Schiffer CA; Wiernik PH
J Clin Oncol; 1987 Sep; 5(9):1364-72. PubMed ID: 3625254
[TBL] [Abstract][Full Text] [Related]
16. Treatment of acute nonlymphocytic leukemia in young and elderly patients.
Beguin Y; Bury J; Fillet G; Lennes G
Cancer; 1985 Dec; 56(11):2587-92. PubMed ID: 4052936
[TBL] [Abstract][Full Text] [Related]
17. Estimate of overall treatment results in acute nonlymphocytic leukemia based on age-specific rates of incidence and of complete remission.
Brincker H
Cancer Treat Rep; 1985 Jan; 69(1):5-11. PubMed ID: 3881178
[TBL] [Abstract][Full Text] [Related]
18. Treatment of childhood acute nonlymphocytic leukemia with individually scheduled high doses of cytarabine: preliminary results of study ANLL-82 of the Dutch Childhood Leukemia Study Group (DCLSG).
Hählen K; van der Does-van den Berg A; Colly LP; Smets LA; Taminiau JA; Vossen JM
Haematol Blood Transfus; 1987; 30():389-92. PubMed ID: 3305208
[No Abstract] [Full Text] [Related]
19. Long-term outcome of postremission chemotherapy for adults with acute myeloid leukemia using different dose-intensities.
Jehn U
Leuk Lymphoma; 1994 Sep; 15(1-2):99-112. PubMed ID: 7532060
[TBL] [Abstract][Full Text] [Related]
20. Reinduction chemotherapy for acute nonlymphocytic leukemia.
Letendre L; Kiely JM; Hoagland HC
Mayo Clin Proc; 1984 Sep; 59(9):618-21. PubMed ID: 6381915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
